SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.

Sci Rep · 2017 · PMC5341046 · PMID 28272475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Our recent study revealed a highly significant upregulation of SLC22A3 transcripts in PDAC tumors compared with non-neoplastic tissues 10 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.